Sipatrigine
CAS: 130800-90-7
Ref. 3D-FFA80090
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
- 2-(4-Methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-4-pyrimidinamine
- 2-(4-Methyl-piperazin-1-yl)-5-(2,3,5-trichloro-phenyl)-pyrimidin-4-ylamine
- 2-(4-Methylpiperazin-1-Yl)-5-(2,3,5-Trichlorophenyl)-Pyrimidin-4-Amine
- 4-Pyrimidinamine, 2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-
- 619C89
- Bw 619C89
- L-Glutamic Acid, N-[4-[2-(2-Amino-4,7-Dihydro-4-8 Oxo-1H-Pyrrolo[2,3-D] Pyrimidin-5-Yl)Ethyl]Benzoyl]-, Disodium Salt, Heptahydrate
- disodium (2S)-2-[({4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl}carbonyl)amino]pentanedioate
Sipatrigine is a drug that belongs to the group of pharmacological agents. It has been shown to have neuroprotective and anti-epileptic effects in animal models. Sipatrigine inhibits voltage-gated potassium channels, slowing the influx of calcium ions into nerve cells and preventing neuronal cell death. It is also an inhibitor of glutamate release, which may contribute to its therapeutic effects. Sipatrigine has a side-effect profile similar to lamotrigine, with the exception of being less sedating.
Propiedades químicas
Consulta técnica sobre: 3D-FFA80090 Sipatrigine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
